Previous Investigations
Other Litigations heparin
|
Why was Oversulfated Condroitin Sulfate used in Heparin?
On March 19, 2008, the New York Times reported that the contaminant in batches of the blood thinner heparin associated with 19 deaths has been identified as Oversulfated Condroitin Sulfate.
Oversulfated condroitin sulfate is less expensive to make than heparin, but FDA officials said they could not estimate the cost difference. FDA officials said they could not yet directly associate the oversulfated condroitin sulfate to the deaths and side effects, but it is the lone contaminant they have found in the product.
Additionally, a different brand of heparin has also been recalled in Germany after 80 patients there became sick, and the German manufacturer said it was narrowing down the source of contamination to another Chinese supplier. However, it is yet to be determined whether the contaminant they are investigating is oversulfated condroitin sulfate.
If you were harmed from heparin contamination, please complete the form below and a representative of our firm will contact you as soon as possible. We hope to assist you in the legal aspects involved with heparin contamination
see also:
Delaware Deaths
Two Deaths in Delaware Hospital May Link to Baxter Heparin: LawyersFree lawsuit reviews to those harmed by Baxter Heparin in Delaware.
Adverse reactions
New York Heparin Lawyers: Adverse reaction from Heparin? Click hereFree case review from Heparin lawyers for those with adverse reactions
Heparin contamination
Information on Heparin contaminationGet FREE lawsuit review about Heparin contamination
